Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Avecho Biotechnology Limited
  6. News
  7. Most relevant
    AVE   AU0000047441

AVECHO BIOTECHNOLOGY LIMITED

(AVE)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about AVECHO BIOTECHNOLOGY LIMITED
10/21AVECHO BIOTECHNOLOGY : Ties Up with Academic Institution for Osteoarthritis Study
MT
10/20Avecho Biotechnology Limited Announces Collaboration with the Lambert Initiative
CI
10/04AVECHO BIOTECHNOLOGY : Begins Dosing Volunteers for Phase 1 Cannabidiol Clinical Trial
MT
10/03Avecho Biotechnology Limited Announces Dosing Commences for Phase I Human Clinical Tria..
CI
09/15AVECHO BIOTECHNOLOGY : Begins Enrolment for Phase 1 Cannabidiol Absorption Trial
MT
09/14Avecho Commences Enrolment for Phase I Human Clinical Trial Measuring CBD Absorption
CI
08/23Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, ..
CI
05/26Avecho Biotechnology to Discuss Cannabidiol Soft-Gel Product with Drug Regulator; Share..
MT
05/21AVECHO BIOTECHNOLOGY : Completes Cannabidiol Soft Gel Product Design; Shares Rally 13%
MT
05/20Avecho Biotechnology Limited Completes Pharmaceutical CBD Soft-Gel Product
CI
05/04Avecho Biotechnology Limited Announces Resignation of Mr. David Segal as Director
CI
04/12AVECHO BIOTECHNOLOGY : Secures Ethics Approval for Cannabidiol Product Test on Humans
MT
04/12Avecho Biotechnology Limited Receives Ethics Approval for Cbd Human Trial
CI
02/25Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December ..
CI
2020Avecho Biotechnology Begins Observational Study on Cannabidiol Formulation; Shares Surg..
MT
2020Avecho Biotechnology Begins Human Trial on CBD Product
CI
2020AVECHO BIOTECHNOLOGY : Anesthetic Clears Toxicology Test; Shares Jump 20%
MT
2020Avecho Biotechnology Limited's Improved Propofol TPM« Formulation for Sedation Passes C..
CI
2020Avecho Biotechnology Limited Provides TPM Cannabinoid Development Program Update
CI
2020Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, ..
CI
2020Avecho Biotechnology Limited Announces Changes to Leadership Team
CI
2020Avecho Announces Medicinal Cannabis Supply Agreement with Tasmanian Alkaloids
CI
2020Avecho Biotechnology Limited Signs Term Sheet for Cannabinoid Supply with Purisys LLC
CI
2020Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December ..
CI
2020Avecho Biotechnology Limited Appoints Matthew Patrick McNamara as Non-Executive Directo..
CI
2019Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, ..
CI
2019Avecho Biotechnology Limited Announces Resignation of Michael Sapountzis as Joint Compa..
CI
2019ISP Investments LLC signed an agreement to acquire Global Exclusive Manufacturing Right..
CI
2019Phosphagenics Limited Announces Management Changes, Effective from April 1, 2019
CI
2019Phosphagenics Limited Auditor Raises 'Going Concern' Doubt
CI
2019Phosphagenics Limited Announces Consolidated Earnings Results for the Full Year Ended D..
CI
2018Phosphagenics Limited Announces Management Changes
CI
2018Phosphagenics Announces Licensing Agreement Update
CI
2018Phosphagenics Limited Announces Consolidated Earnings Results for the Six Months Ended ..
CI
2018Phosphagenics Limited Announces Retirement of Peter Lankau, Non-Executive Director
CI
2018Phosphagenics Limited Auditor Raises 'Going Concern' Doubt
CI
2018Phosphagenics Limited Announces Consolidated Earnings Results for the Year Ended Decemb..
CI
2017Phosphagenics Limited Improves Negative Effects of Heat Stress in Poultry
CI
2017Phosphagenics Limited Announces Signing of Non-Exclusive License Agreement with Rodan +..
CI
2017Phosphagenics Limited Signs Term Sheet TPM Diclofenac Gel in Asia
CI
2017Phosphagenics Limited Announces Earnings Results for the Six Months Ended June 30, 2017
CI
2017Pure Beauty Australia Pty Ltd. completed the acquisition of BioElixia« branded products..
CI
2017Pure Beauty Australia Pty Ltd. agreed to acquire BioElixia« branded products range from..
CI
2017Phosphagenics Limited Announces Retirement of Geert Cauwenbergh as Non-Executive Direct..
CI
2017Phosphagenics Limited Announces Board Changes
CI
2017Phosphagenics Limited and Integrated Animal Health Pty Ltd Signs Settlement Deed to Cea..
CI
2017Phosphagenics Limited Auditor Raises 'Going Concern' Doubt
CI
2017Phosphagenics Limited Announces Audited Consolidated Earnings Results for the Year Ende..
CI
2017Phosphagenics Limited Announces Change of Registered Office and Principal Place of Busi..
CI
2016Phosphagenics Limited Announces Results of Poultry Performance Study in Broilers
CI
2016Phosphagenics Limited Announces Consolidated Earnings Results for the Half Year Ended J..
CI
2016Phosphagenics Limited Completes Grower/Finisher Pig Study
CI
2016Phosphagenics Limited Appoints David Segal as Non-Executive Director
CI
2016Phosphagenics Limited Announces Board Changes
CI
Upcoming event on AVECHO BIOTECHNOLOGY LIMITED
Upcoming sector events